Aura Biosciences, Inc. Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Aura Biosciences, Inc. (AURA) had Class of Warrant or Right, Number of Securities Called by Warrants or Rights of 11.17 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights · last filed 2026-08-11
- 2026-06-30: Class of Warrant or Right, Number of Securities Called by Warrants or Rights 11.17M shares.
- 2026-03-31: Class of Warrant or Right, Number of Securities Called by Warrants or Rights 7.37M shares.
- 2025-12-31: Class of Warrant or Right, Number of Securities Called by Warrants or Rights 7.40M shares.
- 2025-09-30: Class of Warrant or Right, Number of Securities Called by Warrants or Rights 7.40M shares.
| Period end | Class of Warrant or Right, Number of Securities Called by Warrants or Rights |
|---|---|
| 2026-06-30 | 11.17M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 7.37M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 7.40M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 7.40M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 7.40M shares 10-Q · filed 2025-08-13 |
| 2024-12-31 | 12.69K shares 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |